PFM Health Sciences’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,871,969
| Closed | -$2.62M | – | 65 |
|
|
2024
Q4 | $2.62M | Sell |
4,871,969
-5,128,818
| -51% | -$2.76M | 0.16% | 59 |
|
|
2024
Q3 | $9.5M | Sell |
10,000,787
-519,444
| -5% | -$494K | 0.54% | 39 |
|
|
2024
Q2 | $10.3M | Buy |
10,520,231
+97,096
| +0.9% | +$94.7K | 0.51% | 43 |
|
|
2024
Q1 | $16.5M | Hold |
10,423,135
| – | – | 0.77% | 39 |
|
|
2023
Q4 | $8.27M | Hold |
10,423,135
| – | – | 0.5% | 47 |
|
|
2023
Q3 | $8.13M | Buy |
10,423,135
+2,065,893
| +25% | +$1.61M | 0.38% | 55 |
|
|
2023
Q2 | $7.73M | Buy |
8,357,242
+2,364,671
| +39% | +$2.19M | 0.3% | 59 |
|
|
2023
Q1 | $6.53M | Buy |
5,992,571
+1,149,061
| +24% | +$1.25M | 0.29% | 59 |
|
|
2022
Q4 | $7.07M | Sell |
4,843,510
-4,477,074
| -48% | -$6.54M | 0.25% | 60 |
|
|
2022
Q3 | $10M | Buy |
9,320,584
+210,804
| +2% | +$227K | 0.36% | 60 |
|
|
2022
Q2 | $15.5M | Buy |
9,109,780
+6,735,106
| +284% | +$11.4M | 0.59% | 51 |
|
|
2022
Q1 | $4.89M | Sell |
2,374,674
-826,392
| -26% | -$1.7M | 0.18% | 61 |
|
|
2021
Q4 | $12M | Sell |
3,201,066
-1,202,508
| -27% | -$4.51M | 0.41% | 53 |
|
|
2021
Q3 | $22.8M | Buy |
4,403,574
+775,674
| +21% | +$4.01M | 0.67% | 44 |
|
|
2021
Q2 | $15.5M | Buy |
3,627,900
+1,126,597
| +45% | +$4.8M | 0.48% | 54 |
|
|
2021
Q1 | $13.3M | Sell |
2,501,303
-193,466
| -7% | -$1.03M | 0.41% | 51 |
|
|
2020
Q4 | $14.5M | Buy |
2,694,769
+1,845,329
| +217% | +$9.95M | 0.51% | 52 |
|
|
2020
Q3 | $6.78M | Buy |
+849,440
| New | +$6.78M | 0.31% | 62 |
|
|
2015
Q4 | – | Sell |
-1,002,953
| Closed | -$12M | – | 66 |
|
|
2015
Q3 | $12M | Buy |
1,002,953
+37,438
| +4% | +$448K | 0.34% | 56 |
|
|
2015
Q2 | $17.7M | Buy |
+965,515
| New | +$17.7M | 0.45% | 61 |
|